Clinical Trial

Venous Ulcers and Hyaluronic Acid Phonophoresis

Completed
View on ClinicalTrials.gov →
Summary
Venous leg ulcers are severe manifestations of chronic venous insufficiency and account for a large proportion of lower limb ulcers. They typically occur below the knee, persist for more than six weeks, and are associated with significant impairment in quality of life and substantial socioeconomic burden. A major clinical challenge is their high recurrence rate, which can reach 50-70% within six months, making treatment resource-intensive and requiring multidisciplinary care. Therapeutic ultrasound and phonophoresis have been proposed to enhance wound healing by promoting tissue repair and improving transdermal drug delivery, including hyaluronic acid, which supports extracellular matrix restoration and wound healing. However, despite the theoretical advantages of combining ultrasound with hyaluronic acid, robust clinical evidence for its effectiveness in venous leg ulcers remains limited. The study aimed to assess the effect of ultrasound-enhanced hyaluronic acid delivery on venous ulcer healing compared to ultrasound followed by topical application of hyaluronic acid.
Trial Details
NCT Number NCT07626203
Lead Sponsor Cairo University
Conditions Venous Ulcer, Venous Ulcer of Leg
Enrollment 64 participants
Start Date 2024-12-12
Primary Completion 2025-02-20 (estimated)
Study Completion 2025-02-26 (estimated)
Updated on ClinicalTrials.gov 2026-06-04